Clonal architecture of chronic myelomonocytic leukemias
Raphaël Itzykson(Université Paris-Sud), Éric Solary(Inserm), Pierre Fenaux(Hôpital Avicenne), Olivier Kosmider(Centre National de la Recherche Scientifique), Claude Preudhomme(Centre National de la Recherche Scientifique), Olivier Bernard(Universidad Católica de Santa Fe), Guillaume Meurice(Institut Gustave Roussy), Aline Renneville(Université Paris-Sud), Philippe Rameau(Institut Gustave Roussy), Olivier Gagey(Assistance Publique – Hôpitaux de Paris), Margot Morabito(Université Paris-Sud), Michaëla Fontenay, Uwe Platzbecker(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), William Vainchenker(Inserm), Céline Berthon(Université Paris-Sud), Nathalie Droin(Université Paris-Sud), François Delhommeau(Inserm), Cédric Oréar(Institut Gustave Roussy), Lionel Adès(Délégation Paris 7)
Cited by 268
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
|Cell|2004|3.8k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k